Combining Germline and Somatic Pharmacogenomics for Comprehensive Cancer Care



 

This presentation will provide valuable insight into how pharmacogenomics is being used in the leading clinical oncology centers today. Learners will gain a deeper understanding of germline and somatic pharmacogenomics through discussions of real-world applications in clinical scenarios.

Originally published on January 12, 2021


Lecture Presenter

Ryan Nelson, PharmD

Ryan Nelson, PharmD

Senior Pharmacy Consultant
ARUP Laboratories

Ryan Nelson, PharmD, is a senior pharmacy consultant for ARUP Laboratories. His main focus is on the implementation of germline and somatic pharmacogenomics and its related research outcomes. Dr. Nelson comes to ARUP from Moffitt Cancer Center, where he completed a fellowship in personalized cancer medicine.


Objectives

After this presentation, participants will be able to:

  • Discuss somatic and germline applications of pharmacogenomics
  • Describe clinical utilization of somatic pharmacogenomics for targeted therapies
  • Apply clinical utilization of germline pharmacogenomics for supportive care medications, optimized chemotherapy dosing, and mitigating chemotherapeutic adverse drug events in at-risk patients with cancer
  • Demonstrate combining germline and somatic pharmacogenomics in clinical scenarios to provide improved cancer care for your patients

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories